Log in
Read about the MENTOR tool

Neurogenic Bowel Dysfunction treatment assessment

Bowel Dysfunction (NBD) affects up to 80 % of the spinal cord injury (SCI) population. The validated NBD Score allows assessment of the severity of bowel symptoms and correlates with impaired quality of life but does not address clinical decision making in individual patients presenting with an ineffective bowel regimen. Therefore, Monitoring Efficacy of NBD Treatment On Response (MENTOR) was developed by a group of international experts in the field of NBD as a standardised way to quickly and accurately assess the effectiveness of NBD treatment regimen in SCI patients.

Read about the MENTOR tool
Read about the MENTOR tool Read about the MENTOR tool

Evidence on TAI treatment method

A randomized, controlled trial of TAI versus conservative bowel management

Predictive factors for compliance with transanal irrigation

Clinical evidence of Peristeen in reducing UTIs in neurogenic bowel dysfunction

Evidence within specialist areas

Clinical evidence of Peristeen in Low Anterior Resection Syndrome (LARS)

Management guidelines for low anterior resection syndrome – the MANUEL project

Clinical evidence of Peristeen for the treatment of NBD in multiple sclerosis